Sinus Dilation Devices Market Growth By 2026 | Top Key Players Entellus Medical, Inc., Smith & Nephew Plc., Acclarent, Inc., B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, SinuSys Corporation, InnAccel Technologies, and Intersect ENT

Sinusitis is an inflammation of sinus, which causes nose blockage and avoids mucus drainage. Sinus dilation devices are used in patients with nose drainage issues related to nasal sinusitis or sinuses to expand the sinus openings. Different types of sinus dilation devices includes balloon sinuplasty systems, rhinoscopes, sinus stents, and functional endoscopic sinus surgery (FESS), and instruments set for sinuses or sinusitis

Download PDF Brochure @ www.coherentmarketinsights.com/insight/request-pdf/2451

New launches of sinus dilation devices by market players augment growth of the market

Key players in the market are focused on launching novel catheters in order to reduce nasal sinusitis or sinuses and address the critical unmet needs of patients. For instance, in January 2014, Acclarent Inc. launched a new range of Balloon Sinuplasty System, RELIEVA, in the U.S. for the treatment of chronic sinusitis in children. This will help the company to diverge its portfolio for various age groups.

Market Dynamics

Factors driving the sinus dilation devices market are increasing prevalence of chronic sinusitis, growing preference for minimally invasive surgeries, and favorable reimbursement scenario of surgical treatments for hospital outpatient department. According to the Centers for Disease Control and Prevention (CDC), in 2016, around 26.7 million adults in the U.S. were diagnosed with chronic sinusitis.

According to National Center for Biotechnology Information (NCBI), over 600,000 ambulatory sinonasal cases are performed each year in the U.S. Centers for Medicare Services (CMS) reassigned the nasal/sinus endoscopy codes, for instance, sphenoid balloon dilation (31297) and maxillary FESS procedures (31267) were reassigned to higher paying Ambulatory Payment Classifications (APCs). This resulted in a significant payment increase of 52.6%, which increased reimbursed cost of both the endoscopic sinus surgeries from US$ 2,009 in 2015 to US$ 3,066 in 2016.

Similarly, in June 2015, SinuSys Corporation received CE mark for its two new devices to treat frontal and sphenoid sinusitis, in addition to maxillary disease. This will help the company to expand its product portfolio of low-pressure and self-expanding dilation devices.

Key players are focusing on adopting various business strategies such as mergers and acquisitions to enhance its product portfolio. For instance, Stryker Corporation completed the acquisition of Entellus Medical Inc. in February 2018. Through this acquisition, Stryker Corporation would promote products of Entellus Medical Inc.

Request a Sample Copy @ www.coherentmarketinsights.com/insight/request-sample/2451

Detailed Segmentation:

Global Sinus Dilation devices Market, By Product Type:
Balloon Sinuplasty Systems
Rhinoscopes
Sinuscopes
Sinus Stents
Functional Endoscopic Sinus Surgery (FESS) Instruments Set
Others
Global Sinus Dilation devices Market, By End User:
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.